CFO4Life Group, LLC

Position in LLY — ELI LILLY & Co

CIK 1706351 COPPELL, TX

Position in LLY

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$1,905,894

+$483,010 QoQ

Shares Held

1,589

+2.7% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.65%

of 13F equity value

Holder Rank

#2,538

of 4,605 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

CFO4Life Group, LLC holds $7,374,448 across 8 Drug Manufacturers - General names. LLY ranks #2 (25.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	10,539	$2,676,589
2	LLY	ELI LILLY & Co This page	1,589	$1,905,894
3	NVS	Novartis AG	4,916	$770,435
4	AMGN	Amgen Inc	1,340	$485,240
5	ABBV	AbbVie Inc.	1,745	$439,111
6	GILD	Gilead Sciences, Inc.	3,156	$398,729
7	PFE	Pfizer Inc	15,403	$370,904
8	MRK	Merck & Co., Inc.	2,549	$327,546

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,905,894	1,589	+2.7%	Shares	Sole	2026-08-12
2026-03-31	$1,422,884	1,547	-17.5%	Shares	Sole	2026-05-11
2025-12-31	$2,015,025	1,875	+1.8%	Shares	Sole	2026-02-06
2025-09-30	$1,404,683	1,841	+0.7%	Shares	Sole	2025-11-07
2025-06-30	$1,424,980	1,828	-1.5%	Shares	Sole	2025-08-08
2025-03-31	$1,532,888	1,856	+78.5%	Shares	Sole	2025-04-30
2024-12-31	$802,880	1,040	+3.4%	Shares	Sole	2025-02-10
2024-09-30	$891,255	1,006	+2.1%	Shares	Sole	2024-11-12
2024-06-30	$891,799	985	+7.1%	Shares	Sole	2024-07-31
2024-03-31	$715,723	920	-5.2%	Shares	Sole	2024-05-06
2023-12-31	$565,432	970	-20.8%	Shares	Sole	2024-02-12
2023-09-30	$657,447	1,224	+53.4%	Shares	Sole	2023-10-30
2023-06-30	$374,246	798	—	Shares	Sole	2023-08-07
No filing history on record for this holder in this stock.